The part number 1769-CLL1 is not related to a specific product or technology in the fields of medicine, biology, or technology. our research provided are all related to the topic of CLL1, which stands for C-type lectin-like molecule-1, a protein that has been researched for its potential as a therapeutic target in the treatment of acute myeloid leukemia (AML).
The results include studies on the efficacy of CLL1-targeting CAR T-cell therapy in patients with relapsed/refractory AML, highlighting the potential benefits of this approach in improving treatment outcomes for these patients. The studies also discuss the safety and tolerability of CLL1 CAR T-cell therapy, including the management of side effects such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome.
The technical specifications, alarm/error codes, user manuals, troubleshooting, programming, and installation details for the part number 1769-CLL1 are not applicable as this part number does not correspond to a specific product or technology in these fields.
Go to product